Comparison between Aptus Pharma IPO and Dachepalli Publishers IPO.
Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Dachepalli Publishers IPO is a SME Bookbuilding proposed to list at BSE SME.
| Aptus Pharma IPO | Dachepalli Publishers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Synfinx Capital Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Market-Hub Stock Broking Pvt.Ltd. | JSK Securities & Services Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aptus Pharma IPO is up to ₹12.36 Cr whereas the issue size of the Dachepalli Publishers IPO is up to ₹38.36 Cr. The final issue price of Aptus Pharma IPO is ₹70.00 per share and of Dachepalli Publishers IPO is ₹102.00 per share.
| Aptus Pharma IPO | Dachepalli Publishers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹100.00 per share |
| Issue Price (Upper) | ₹70.00 per share | ₹102.00 per share |
| Issue Price (Final) | ₹70.00 per share | ₹102.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1200 shares |
| Fresh Issue Size | 17,66,000 shares | 37,60,800 shares |
| Fresh Issue Size (Amount) | up to ₹12.36 Cr | up to ₹38.36 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,66,000 shares | 37,60,800 shares |
| Issue Size Total (Amount) | up to ₹12.36 Cr | up to ₹38.36 Cr |
Aptus Pharma IPO opens on Sep 23, 2025, while Dachepalli Publishers IPO opens on Dec 22, 2025. The closing date of Aptus Pharma IPO and Dachepalli Publishers IPO is Sep 25, 2025, and Dec 24, 2025, respectively.
| Aptus Pharma IPO | Dachepalli Publishers IPO | |
|---|---|---|
| Anchor Bid Date | Sep 22, 2025 | Dec 19, 2025 |
| Issue Open | Sep 23, 2025 | Dec 22, 2025 |
| Issue Close | Sep 25, 2025 | Dec 24, 2025 |
| Basis Of Allotment (Tentative) | Sep 26, 2025 | Dec 26, 2025 |
| Initiation of Refunds (Tentative) | Sep 29, 2025 | Dec 29, 2025 |
| Credit of Share (Tentative) | Sep 29, 2025 | Dec 29, 2025 |
| Listing date (Tentative) | Sep 30, 2025 | Dec 30, 2025 |
| Anchor Lockin End date 1 | Oct 26, 2025 | Jan 24, 2026 |
| Anchor Lockin End date 2 | Dec 25, 2025 | Mar 25, 2026 |
Aptus Pharma IPO P/E ratio is 11.29, as compared to Dachepalli Publishers IPO P/E ratio of 14.86.
| Aptus Pharma IPO | Dachepalli Publishers IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Aptus Pharma Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Dachepalli Publishers Ltd.'s revenue increased by 26% and profit after tax (PAT) rose by 128% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 88.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.89 | 64.78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.29 | 14.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹48.02 Cr. | ₹152.76 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.50% | 32.12% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.66% | 18.22% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.20 | ₹6.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 44.50% | 27.68% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aptus Pharma IPO Retail Individual Investors (RII) are offered 6,20,000 shares while in Dachepalli Publishers IPO retail investors are offered 6,20,000 shares. Qualified Institutional Buyers (QIB) are offered 3,52,000 shares in Aptus Pharma IPO and 7,52,400 shares in Dachepalli Publishers IPO.
| Aptus Pharma IPO | Dachepalli Publishers IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,28,000 shares | 11,25,600 shares |
| Market Maker Reservation | 94,000 shares | 1,99,200 shares |
| QIB | 3,52,000 shares | 7,52,400 shares |
| NII | 2,66,000 shares | 5,65,200 shares |
| RII | 6,20,000 shares | 13,17,600 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 17,66,000 shares | 37,60,800 shares |
Aptus Pharma IPO subscribed 22.27x in total, whereas Dachepalli Publishers IPO subscribed 1.97x.
| Aptus Pharma IPO | Dachepalli Publishers IPO | |
|---|---|---|
| QIB (times) | 1.24x | 1.29x |
| NII (times) | 28.75x | 3.04x |
| Big NII (times) | 30.64x | 3.50x |
| Small NII (times) | 24.93x | 2.11x |
| RII (times) | 31.43x | 1.90x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 22.27x | 1.97x |
